Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Phase 1 human trials have been registered in some geographies Published human efficacy data at the level of a completed, results-reported phase 2 study are not yet a settled part of the dataset Commercial development is active but has not produced a near-term approval path Patients and clinicians tracking 5-amino-1MQ should monitor ClinicalTrials.gov and peer-reviewed publications for current status
For clinician-directed use
We recognize the significance of both physical and emotional well-being
"Dietary supplements and weight control in a middle-age population"
Eligibility for weight loss injections typically requires a BMI 30 kg/m or 27 kg/m with at least one weight-related complication (such as hypertension, dyslipidemia, type 2 diabetes, or MASLD)
US$ 25.38
US$ 20.93
US$ 28.40
